Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.
McGann KC, Woodhouse P, Chen H, Kammer MN, Holmes HM, Lopez C, Pass HI, Tsay JJ, Lenburg ME, Dubinett SM, Willey JC, Herman JG, Schabath MB, Khalil TA, Zou Y, Potter MH, Chen SC, Argaw SA, Meyers P, Fischer S, Tran C, Forero YJ, Antic S, Paez R, Lila E, Barón AE, Maldonado F, Deppen SA, Grogan EL.
McGann KC, et al. Among authors: potter mh.
Cancer Epidemiol Biomarkers Prev. 2026 Jun 3:OF1-OF8. doi: 10.1158/1055-9965.EPI-25-2004. Online ahead of print.
Cancer Epidemiol Biomarkers Prev. 2026.
PMID: 42233870